Today: 27/06/2022 07:12:55 (GMT+7)
THE CENTRAL AGENCY OF THE COMMUNIST PARTY OF VIETNAM BAC GIANG PROVINCE THE VOICE OF THE PARTY, GOVERNMENT AND PEOPLE OF BAC GIANG PROVINCE

100 volunteers join clinical trials of ARCT-154 Covid-19 vaccine

The Hanoi Medical University started the first phase of clinical trials of the ARCT-154 Covid-19 vaccine on August 15, with the participation of 100 volunteers from Hanoi.

Previously, on August 2, the Ministry of Health (MoH) issued Decision No. 3679/QD-BYT approving a proposal on human clinical trials of the ARCT-154 vaccine.

100 volunteers, clinical trials, ARCT-154 Covid-19 vaccine, Hanoi Medical University, first phase, human clinical trials

Prof. Dr. Ta Thanh Van and Prof. Dr. Tran Van Thuan witness the ARCT-154 vaccine injection for a volunteer.

The clinical trials will be carried out in three phases with the participation of 21,000 volunteers, including 100 in phase one, 300 in phase two and 20,600 in phase three.

Deputy Health Minister, Prof. Dr. Tran Van Thuan highly appreciated the careful preparation, enthusiasm, and responsibility of scientists from the Hanoi Medical University as well as facilities participating in the clinical trial.

He expressed his belief that under the direction of the Government and the Prime Minister, with the help of domestic and international experts, the clinical trial of the vaccine will soon be successful and Vietnam will soon become self-sufficient in vaccines against Covid-19.

This was the third vaccine, following Nanocovax -developed by Nanogen in Ho Chi Minh City, which is in phase 3 of trials, and the Covivax vaccine, currently in phase 2, in the series of research and technology transfers under the direction of the Government.

According to Prof. Dr. Ta Thanh Van, Chairman of the Hanoi Medical University's Council, who is the main researcher of the ARCT-154 vaccine clinical trial, just two days after announcing the recruitment of volunteers, more than 800 people had registered to join and, through screening, more than 100 qualified people have been selected.

According to the MoH, ARCT-154 is the first vaccine in Vietnam developed with mRNA technology. The vaccine is designed to act against coronavirus variants, including Alpha, Beta, Delta, Gamma, etc.

Vietnam recruits volunteers for trials of ARCT-154 Covid-19 vaccine
Volunteers are being recruited for clinical trials of ARCT-154, a Covid-19 vaccine developed by a US company, whose manufacturing rights have been secured by VinBioCare, a subsidiary of VinGroup.
 
Expats offer to present 50,000 Covid-19 vaccine vials to Ho Chi Minh City
Lawyer Vo Duc Duy, a Vietnamese national in the US, and his colleagues have expressed their wish to present 50,000 vials of Moderna Covid-19 vaccine to Ho Chi Minh City which is being hit hard by the pandemic.
 
HCMC to receive 600,000 more Covid-19 vaccine doses
Ho Chi Minh City will receive 600,000 AstraZeneca vaccine doses from Pasteur Institute to continue mass inoculation.
 
HCMC nearly out of allocated Covid-19 vaccine doses
The current speed of vaccination can see HCMC run out of the Covid-19 vaccine doses that the Ministry of Health has allocated to the city.
 
Urgent meeting held to evaluate homegrown Covid-19 vaccine Nano Covax
The National Ethics Committee in Biomedical Research under the Ministry of Health on August 7 held an urgent online meeting to review the results of the first phase of clinical trials of Vietnam’s domestically developed Covid-19 vaccine, Nano Covax, and to pass the mid-term assessment of its second phase.
 

Source: NDO

100 volunteers, clinical trials, ARCT-154 Covid-19 vaccine, Hanoi Medical University, first phase, human clinical trials
 
New comment has just been added. Click here
Sort:NewBest News